NCT03353298View on ClinicalTrials.gov

Lowering Uric Acid in Live Kidney Donors

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

September 25, 2020

Study Completion Date

September 25, 2020

Conditions
Renal Transplant Donor of Left KidneyRenal Transplant Donor of Right Kidney
Interventions
DRUG

Allopurinol 300 mg

Allopurinol oral tablets 300 mg given to participants once daily for 9 months

DRUG

Placebo Oral Tablet

placebo oral tablets given to participants once daily for 9 months

Trial Locations (1)

Unknown

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

South-Eastern Norway Regional Health Authority

OTHER

collaborator

University of Oslo

OTHER

lead

Oslo University Hospital

OTHER

NCT03353298 - Lowering Uric Acid in Live Kidney Donors | Biotech Hunter | Biotech Hunter